The performance of EDM has been validated both through independently conducted, randomized controlled trials and through audited implementations into routine practice. Based on this evidence, EDM has been recommended by government entities, health payers and technology assessment bodies.

Esophageal Doppler Monitoring (EDM) has gained support from a number of clinical and regulatory bodies, both within the US and internationally, due to the robust evidence available; demonstrating reduced post-operative complications and hospital length of stay.

330 E. Coffee Street | Greenville | SC 29601 | USA

  • Enquiries: +1 864 527 5913
  • Email:
  • Deltex App:


Registered in England & Wales Company No: 1691369